Perspektiven Es sind mehrere Phase-II- und Phase-III-Studien im Gange, welche andere Therapiemöglichkeiten der Zöliakie prüfen. Dazu gehören Gliadin-spaltende Enzyme, Tightjunction-Agonisten oder die Impfung. Wie eine glutenfreie Diät durchgeführt wird, sollte immer zusammen mit einer Ernährungsberatung besprochen werden. Zudem empfehlen die Autoren auch, dass Neudiagnostizierte der IG Zöliakie (der Schweizerischen Patientenorganisation) beitreten. Bezüglich der Nachsorge soll neben der periodischen Bestimmung der Zöliakie-Antikörper auch eine jährliche Bestimmung von Blutbild sowie von Vitaminen und Spurenelementen (Ferritin, Zink, Vitamin B12, Folsäure, Vi tamin D) erfolgen. Und zu guter Letzt sollte eine Osteodensitometrie nicht vergessen werden. 1 Zentrum für Gastroenterologie und Hepatologie, Zürich, Schweiz 2 GastroZentrum Hirslanden, Zürich, Schweiz 3 Klinik für Gastroenterologie und Hepatologie, UniversitätsSpital Zürich, Zürich, Schweiz Anzeige Lachen und Träume für unsere Kinder im Spital Foto: P.-Y. Massot. Anzeige offeriert. Jede Woche erhalten die Kinder im Spital Besuch von den Traumdoktoren. Ihre Spende schenkt Lachen. PC 10-61645-5 Herzlichen Dank. 44 ZürichseeWerbeAG_210x148_CH-FR-DE-IT.indd 2 24.04.19 14:05 4/20 <strong>VSAO</strong> /ASMAC Journal
Perspektiven Referenzen 1. Green PH, Cellier C. Celiac disease. N Engl J Med. 2007; 357(17):1731–43. Epub 2007/10/26. doi: 10.1056/NEJMra071600. PubMed PMID: 17960014. 2. Green PH, Krishnareddy S, Lebwohl B. Clinical manifestations of celiac disease. Dig Dis. 2015; 33(2):137–40. Epub 2015/05/01. doi: 10.1159/000370204. PubMed PMID: 25925914. 3. Booth C. History of celiac disease. BMJ. 1989; 298: 527. 4. Paulley JW. Observation on the aetiology of idiopathic steatorrhoea; jejunal and lymph-node biopsies. Br Med J. 1954; 2(4900): 1318–21. Epub 1954/12/04. doi: 10.1136/ bmj.2.4900.1318. PubMed PMID: 13209109; PubMed Central PMCID: PMCPMC2080246. 5. Riddle MS, Murray JA, Porter CK. The incidence and risk of celiac disease in a healthy US adult population. Am J Gastroenterol. 2012; 107(8): 1248–55. Epub 2012/05/16. doi: 10.1038/ ajg.2012.130. PubMed PMID: 22584218; PubMed Central PMCID: PMCPMC3493152. 6. Green PH, Lebwohl B, Greywoode R. Celiac disease. J Allergy Clin Immunol. 2015; 135(5): 1099–106; quiz 107. Epub 2015/05/10. doi: 10.1016/j. jaci.2015.01.044. PubMed PMID: 25956012. 7. Lebwohl B, Sanders DS, Green PHR. Coeliac disease. Lancet. 2018; 391(10115): 70–81. Epub 2017/08/02. doi: 10.1016/ S0140-6736(17)31796-8. PubMed PMID: 28760445. 8. Maki M, Mustalahti K, Kokkonen J, Kulmala P, Haapalahti M, Karttunen T, et al. Prevalence of Celiac disease among children in Finland. N Engl J Med. 2003; 348(25): 2517–24. Epub 2003/06/20. doi: 10.1056/NEJMoa021687. PubMed PMID: 12815137. 9. Di Sabatino A, Corazza GR. Coeliac disease. Lancet. 2009; 373(9673): 1480–93. Epub 2009/04/28. doi: 10.1016/ S0140-6736(09)60254-3. PubMed PMID: 19394538. 10. Dube C, Rostom A, Sy R, Cranney A, Saloojee N, Garritty C, et al. The prevalence of celiac disease in average-risk and at-risk Western European populations: a systematic review. Gastroenterology. 2005;128(4 Suppl 1): S57–67. Epub 2005/04/13. doi: 10.1053/j. gastro.2005.02.014. PubMed PMID: 15825128. 11. West J, Logan RF, Hill PG, Lloyd A, Lewis S, Hubbard R, et al. Seroprevalence, correlates, and characteristics of undetected coeliac disease in England. Gut. 2003; 52(7): 960–5. Epub 2003/06/13. doi: 10.1136/ gut.52.7.960. PubMed PMID: 12801951; PubMed Central PMCID: PMCPMC1773707. 12. Fasano A, Berti I, Gerarduzzi T, Not T, Colletti RB, Drago S, et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med. 2003; 163(3): 286–92. Epub 2003/02/13. doi: 10.1001/archinte.163.3.286. PubMed PMID: 12578508. 13. Lebwohl B, Green P. Risk of celiac disease according to HLA haplotype and country. N Engl J Med. 2014; 371(11): 1073–4. Epub 2014/09/11. doi: 10.1056/NE JMc1409252. PubMed PMID: 25207778. 14. Rubio-Tapia A, Kyle RA, Kaplan EL, Johnson DR, Page W, Erdtmann F, et al. Increased prevalence and mortality in undiagnosed celiac disease. Gastroenterology. 2009; 137(1): 88–93. Epub 2009/04/14. doi: 10.1053/j.gastro.2009.03.059. PubMed PMID: 19362553; PubMed Central PMCID: PMCPMC2704247. 15. Lohi S, Mustalahti K, Kaukinen K, Laurila K, Collin P, Rissanen H, et al. Increasing prevalence of coeliac disease over time. Aliment Pharmacol Ther. 2007; 26(9): 1217–25. Epub 2007/10/20. doi: 10.1111/j.1365-2036.2007.03502.x. PubMed PMID: 17944736. 16. Du Y, Shan LF, Cao ZZ, Feng JC, Cheng Y. Prevalence of celiac disease in patients with Down syndrome: a meta-analysis. Oncotarget. 2018; 9(4): 5387–96. Epub 2018/02/13. doi: 10.18632/ oncotarget.23624. PubMed PMID: 29435186; PubMed Central PMCID: PMCPMC5797057. 17. Bardella MT, Fredella C, Saladino V, Trovato C, Cesana BM, Quatrini M, et al. Gluten intolerance: gender- and age-related differences in symptoms. Scand J Gastroenterol. 2005; 40(1): 15–9. Epub 2005/04/22. doi: 10.1080/00365520410008169. PubMed PMID: 15841709. 18. Sollid LM, Lie BA. Celiac disease genetics: current concepts and practical applications. Clin Gastroenterol Hepatol. 2005; 3(9): 843–51. Epub 2005/10/20. PubMed PMID: 16234020. 19. Dieterich W, Ehnis T, Bauer M, Donner P, Volta U, Riecken EO, et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med. 1997; 3(7): 797–801. Epub 1997/07/01. doi: 10.1038/nm0797- 797. PubMed PMID: 9212111. 20. Molberg O, McAdam SN, Korner R, Quarsten H, Kristiansen C, Madsen L, et al. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat Med. 1998; 4(6): 713–7. Epub 1998/06/12. doi: 10.1038/nm0698-713. PubMed PMID: 9623982. 21. Lundin KE, Scott H, Hansen T, Paulsen G, Halstensen TS, Fausa O, et al. Gliadin-specific, HLA-DQ(alpha 1*0501,beta 1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients. J Exp Med. 1993; 178(1): 187–96. Epub 1993/07/01. doi: 10.1084/jem.178.1.187. PubMed PMID: 8315377; PubMed Central PMCID: PMCPMC2191064. 22. Daum S, Bauer U, Foss HD, Schuppan D, Stein H, Riecken EO, et al. Increased expression of mRNA for matrix metalloproteinases-1 and -3 and tissue inhibitor of metalloproteinases-1 in intestinal biopsy specimens from patients with coeliac disease. Gut. 1999; 44(1): 17–25. Epub 1998/12/24. doi: 10.1136/gut.44.1.17. PubMed PMID: 9862821; PubMed Central PMCID: PMCPMC1760063. 23. Schuppan D, Junker Y, Barisani D. Celiac disease: from pathogenesis to novel therapies. Gastroenterology. 2009; 137(6): 1912–33. Epub 2009/09/22. doi: 10.1053/j.gastro.2009.09.008. PubMed PMID: 19766641. 24. Riddle MS, Murray JA, Cash BD, Pimentel M, Porter CK. Pathogen-specific risk of celiac disease following bacterial causes of foodborne illness: a retrospective cohort study. Dig Dis Sci. 2013; 58(11): 3242–5. Epub 2013/07/03. doi: 10.1007/s10620-013-2733-7. PubMed PMID: 23812827. 25. Welander A, Tjernberg AR, Montgomery SM, Ludvigsson J, Ludvigsson JF. Infectious disease and risk of later celiac disease in childhood. Pediatrics. 2010; 125(3): e530-6. Epub 2010/02/24. doi: 10.1542/peds.2009-1200. PubMed PMID: 20176673. 26. Akobeng AK, Ramanan AV, Buchan I, Heller RF. Effect of breast feeding on risk of coeliac disease: a systematic review and meta-analysis of observational studies. Arch Dis Child. 2006; 91(1): 39–43. Epub 2005/11/17. doi: 10.1136/adc.2005.082016. PubMed PMID: 16287899; PubMed Central PMCID: PMCPMC2083075. 27. Chin RL, Sander HW, Brannagan TH, Green PH, Hays AP, Alaedini A, et al. Celiac neuropathy. Neurology. 2003; 60(10): 1581–5. Epub 2003/05/29. doi: 10.1212/01.wnl.0000063307.84039. c7. PubMed PMID: 12771245. 28. Wierdsma NJ, van Bokhorst-de van der Schueren MA, Berkenpas M, Mulder CJ, van Bodegraven AA. Vitamin and mineral deficiencies are highly prevalent in newly diagnosed celiac disease patients. Nutrients. 2013; 5(10): 3975–92. Epub 2013/10/03. doi: 10.3390/nu5103975. PubMed PMID: 24084055; PubMed Central PMCID: PMCPMC3820055. 29. Donaldson MR, Zone JJ, Schmidt LA, Taylor TB, Neuhausen SL, Hull CM, et al. Epidermal transglutaminase deposits in perilesional and uninvolved skin in patients with dermatitis herpetiformis. J Invest Dermatol. 2007; 127(5): 1268–71. Epub 2007/01/06. doi: 10.1038/sj.jid.5700682. PubMed PMID: 17205060. 30. Sticherling M, Erfurt-Berge C. Autoimmune blistering diseases of the skin. Autoimmun Rev. 2012; 11(3): 226–30. Epub 2011/06/07. doi: 10.1016/j.autrev.2011.05.017. PubMed PMID: 21640850. <strong>VSAO</strong> /ASMAC Journal 4/20 45
Change language